Research Article

Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials

Table 3

Methodologic quality of the included studies.

StudyRandom sequence generationAllocation concealmentBlinding of participants and personnelBlinding of outcome assessmentIncomplete outcome dataSelective reportingOther bias

Zhang [46]UnclearUnclearUnclearUnclearLowUnclearUnclear
Yao [44]LowUnclearUnclearUnclearLowUnclearUnclear
Liu [33]UnclearHighUnclearUnclearLowUnclearUnclear
Luo [35]UnclearUnclearUnclearUnclearLowUnclearLow
Wang [40]UnclearUnclearLowUnclearLowUnclearLow
Yang [43]LowUnclearLowLowLowUnclearUnclear
Deng [25]LowUnclearUnclearUnclearLowUnclearUnclear
Liu [32]UnclearHighLowLowLowUnclearUnclear
Shen [20]LowLowLowLowLowLowUnclear
Wang [22]LowUnclearLowLowLowUnclearLow
He [29]LowUnclearUnclearUnclearLowUnclearUnclear
Zhang [45]UnclearUnclearLowLowLowUnclearUnclear
Pan [38]UnclearHighLowLowLowUnclearUnclear
Bai [23]UnclearUnclearUnclearUnclearLowUnclearUnclear
Liang [31]LowUnclearUnclearUnclearLowUnclearUnclear
Li [30]UnclearUnclearUnclearUnclearLowUnclearUnclear
Wen [41]LowUnclearUnclearUnclearLowUnclearLow
Zheng [48]UnclearUnclearUnclearUnclearLowUnclearUnclear
Gong [28]LowUnclearUnclearUnclearLowUnclearUnclear
Gao [27]LowUnclearUnclearUnclearLowUnclearLow
Ma [36]LowUnclearUnclearUnclearLowUnclearUnclear
Zhu [50]LowUnclearUnclearUnclearLowUnclearUnclear
Zhang [47]UnclearUnclearUnclearUnclearLowUnclearUnclear
Deng [26]LowUnclearUnclearUnclearLowUnclearUnclear
Ma [37]UnclearUnclearUnclearUnclearLowUnclearUnclear
Yan [52]UnclearUnclearUnclearUnclearLowUnclearUnclear
Liang [51]UnclearUnclearUnclearUnclearLowUnclearUnclear
Zhu [49]LowUnclearUnclearUnclearLowUnclearUnclear
He [21]UnclearUnclearLowUnclearLowUnclearLow
Wang [39]UnclearUnclearLowLowLowUnclearUnclear
Chen [24]LowUnclearUnclearUnclearLowUnclearUnclear
Lu [34]UnclearUnclearUnclearUnclearLowUnclearUnclear
Xu [42]UnclearUnclearUnclearUnclearLowUnclearUnclear